Liraglutide for Low-responders After Bariatric Surgery
Latest Information Update: 28 Apr 2021
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms LIBAR
- 22 Apr 2021 According to ClinicalTrials.gov, this study was discontinued because of cancellation by sponsor.
- 23 Feb 2021 Status changed from recruiting to discontinued.
- 02 Feb 2021 Status changed from not yet recruiting to recruiting.